אמנים לעקוב
רצועות מובילות שבועיות
- לְגַלוֹת
- הזנה
- מוזיקה חדשה
- מוזיקה מובילה
- אלבומים
- זַרקוֹר
- ז'אנרים
- רשימות השמעה
- היכל התהילה
- לצבור נקודות
דפדף במוזיקה
- שיחק לאחרונה
- הפלייליסטים שלי
- מועדפים
המוזיקה שלך
- זָכָר
- קשרים חברתיים
- הוא היה
-
The development of hormonal therapies led to a drastic decline in prostate cancer deaths in the mid-1990s. Prostate cancer requires male sex hormones called androgens to grow. For many men, living a full life with good energy and drive is possible, even with a history of prostate cancer. So, what does this mean for you, especially if you’ve already been treated for prostate cancer? Once the cancer cells have absorbed a small amount of testosterone, giving them more doesn’t really speed up their growth. Prostate cancer cells seem to work in a similar way with testosterone. Doctors found that if a man had prostate cancer that had spread, removing his testicles dramatically slowed the cancer down.
After a median follow up of 2.5 years, two men had upgrading on subsequent biopsy, but no cases of disease or PSA progression were seen Morgentaler et al. 2011. Studies on TRT in patients with PrCa enrolled in active surveillance (AS) programs provide valuable information on possible tumor progression in PrCa patients, given the frequency of exams, biopsies and close follow up in this population. Leibowitz and colleagues reported on 96 men with PrCa who began high-dose TRT after undergoing primary PrCa treatment. There was an overall increase in serum PSA, but no evidence of increased cancer recurrence over 36 months Pastuszak et al. 2013.
In contrast, in the European Male Aging Study (EMAS), using criteria of testosterone Wu et al. 2010. Prevalence estimates of LOH vary widely depending on study methods, populations and diagnostic criteria used. In a large, multi-institutional study of 3369 men aged 40 to 79 years, the European Male Aging Study (EMAS) attempted to better define the symptom complex of LOH. The decline in total testosterone is further influenced by an increase in SHBG that occurs with aging, which may lower bioavailable testosterone Vermeulen and Kaufman, 1995; Muller et al. 2003. The resulting amplitude of peak morning testosterone is decreased in older men, making morning testosterone measurement a useful laboratory marker in the diagnosis of LOH Bremner et al. 1983; Tenover et al. 1988; Wang et al. 2008. For instance, Ellison and colleagues demonstrated young adult elevations in testosterone and subsequent age-related declines in US and Congo populations, but not in Nepal or Paraguay Ellison et al. 2002. DHT also plays a well-established role in promoting continued growth of the adult prostate, leading to benign prostatic hypertrophy (BPH) Huggins, 1947; Andriole et al. 2004.|Survival rates aren’t as good if the cancer spreads — 32% of people with metastatic prostate cancer are alive five years after diagnosis. In many cases, treatment can eliminate cancers that stay in the prostate. You have an excellent outlook when prostate cancer is found early. Focal therapy is a newer form of treatment that destroys tumors inside your prostate. If cancer spreads outside your prostate, your oncologist may recommend systemic treatments. It can often successfully eliminate prostate cancers that haven’t spread.|In the end, the use of TRT in prostate cancer patients is still considered experimental and should only be offered after well-informed shared decision making and with close monitoring. Despite these fears, there are a growing number of studies demonstrating no increase in prostate cancer incidence among men on TRT. The ‘androgen hypothesis’ asserts that prostate cancer development and progression is driven by androgens, and thus TRT has the theoretical potential to drive prostate cancer development and progression. Over the last decade, increased awareness of hypogonadism among patients and providers has led to a significant rise in the use of testosterone replacement therapy (TRT) for hypogonadism, and especially in LOH. Together, you and your healthcare provider will weigh the risks and benefits of TRT to see if it could help. Testosterone replacement therapy can improve many of the symptoms of low testosterone (male hypogonadism). Before starting TRT, your healthcare provider will make sure low testosterone is an accurate diagnosis.|Just like so many families dealing with the disease—in the U.S. more than 300,000 new cases are expected to be diagnosed in the next year—the Romos know there can be uncertainty. "When you find out you have cancer, it’s a lot to process," he says. He wanted to know if his dad’s cancer was rare or common, and what the numbers said.|Not only that, but the cancer they have is often a more aggressive type. This simple idea has opened up entirely new possibilities for men’s health. They use testosterone to grow, but only up to a certain point. This one idea shaped how doctors treated patients for generations. If taking testosterone away helped, then adding it must be dangerous. Since testicles make most of the body’s testosterone, the logic seemed simple.|Androgens, including exogenous testosterone, have been shown to play a role in PrCa pathogenesis in cell lines and animal models Bladou et al. 1996; Ahmad et al. 2008. In analyzing the placebo arm, researchers identified no association of testosterone or DHT with PrCa incidence or Gleason grade Muller et al. 2012. Of 145 cases of PrCa, 36 were categorized as high risk, based on modified D’Amico criteria D’Amico et al. 2003. Using serum samples and PrCa incidence data from the Physicians’ Health Study, Gann and colleagues identified 222 men with PrCa and 399 controls, matched for age, smoking status and follow up. Likewise, androgens promote tumorigenesis and xenograft growth in animal models, and tumor regression is seen upon androgen deprivation Bladou et al. 1996; Ahmad et al. 2008. Percentage of hypogonadal men, with total serum testosterone of Data from Wu et al. and Harmon et al. . Using both laboratory and symptoms for diagnosis, the Massachusetts Male Aging Study estimated that 2.4 million US men met criteria for LOH Araujo et al. 2004.|"Nature has designed a system where low doses of hormones stimulate cancer cell proliferation and high doses cause differentiation and suppress growth, enabling the same hormone to perform diverse functions," McDonnell said. In doing so, it activates the pathways that cause cancer cells to grow and spread. When androgen levels are low, the androgen receptor is encouraged to "go solo" in the cell. Hormone therapy also increases the likelihood of other treatment options, such as radiation therapy, being effective. Androgens can also help prostate cells grow by connecting to proteins that express the genes that lead to growth.|This can help improve the symptoms of low testosterone, like low libido and lack of energy. With TRT, you take a manufactured form of testosterone to regulate your levels. Together, you and your healthcare provider will decide if TRT is right for you. There will also be questions about which patients are best suited to this approach , how it interacts with newer generations of hormonal drugs and whether long-term effects on the heart remain reassuring. This "transdermal" delivery - through the skin rather than the stomach - avoids the liver processing the hormone and appears to blunt some of the heart and clotting risks historically linked to oestrogen tablets taken by mouth. Talk to your healthcare provider if you have concerns about fertility.|Prostate cancer develops in the walnut-shaped gland in your pelvis that produces fluid to help nourish and transport sperm. Hormone therapy can involve taking medications or surgically removing your testicles. We now know that the old belief that testosterone is like fuel for a fire is just too simple for a complex issue.}
As such, we examine the role of endogenous testosterone in patients without PrCa, the role of endogenous testosterone in PrCa patients, and the potential oncologic risks of exogenous testosterone from TRT in PrCa patients. Your provider is there to support you in all aspects of your health. If symptoms of low testosterone are interfering with your quality of life, know that you don’t have to just grin and bear it. For all these reasons, your healthcare provider will carefully consider if TRT is safe for you based on your unique characteristics. For example, some studies suggest that TRT decreases your risk of heart attack over time, while others say it increases your risk..|Although this new information is somewhat reassuring, men and their doctors should still weigh these issues before committing to long term testosterone therapy. A relatively small number of men experience immediate side effects of testosterone supplementation, such as acne, disturbed breathing while sleeping (worsening sleep apnea), breast swelling or tenderness, or swelling in the ankles. Men can often feel a big difference when they stop therapy because their body's testosterone production has not yet recovered. On treatment, the body stops making testosterone.|Oestradiol, the form of oestrogen in standard HRT patches, signals to the brain that there is plenty of sex hormone around. They are effective, but they are blunt tools, dragging down oestrogen as well as testosterone and taking a heavy toll on quality of life with hot flushes, brittle bones and metabolic problems. Elizabeth Millard is a freelance writer focusing on health, wellness, fitness, and food. You are encouraged to report side effects or quality complaints of products to the FDA by visiting /medwatch or calling FDA- 1088. These are not all the possible side effects of NUBEQA.|So how can this paradox exist with evidence that normal testosterone levels are not harmful? Recent medical studies now show that testosterone treatment is safe. This led to the proposal of the "saturation model", which suggests that prostate tissue is sensitive to testosterone only at very low levels. "We have already developed new drugs that exploit this new mechanism and are bringing these to the clinic for evaluation as prostate cancer therapeutics."|There are a number of studies examining testosterone levels prior to prostate biopsy in men with suspected PrCa. A prospective cohort study of Korean men undergoing prostate biopsy for suspected PrCa compared biopsy results among men with low testosterone, defined as total testosterone levels below the median of 13.3 nmol/l (385 ng/dl). It should be noted that longitudinal studies of this kind are limited in that serum testosterone levels were not routinely drawn in the morning, and thus may not reflect the true peak circulating androgen levels.|The fear linking testosterone to prostate cancer didn’t come out of nowhere. Let’s clear up the confusion surrounding testosterone and prostate cancer so you can make decisions that feel right for you. The connection between testosterone and prostate cancer is far more complex than that simple, terrifying idea.|Cancer staging allows your provider to determine how advanced your cancer is, or how much it’s spread. The Gleason score allows your provider to determine the grade of your cancer, or its potential to be aggressive. Faster-growing cancers or those that have spread outside the prostate usually need a biopsy to confirm the diagnosis. Most tumors are diagnosed before the cancer has spread beyond your prostate. While normal cells eventually die, cancer cells don’t.}
Similarly, in a large meta-analysis Roddam and colleagues examined the relationship between testosterone and PrCa in patients pooled from the Endogenous Hormones and Prostate Cancer Collaborative Group, which included data from 3886 PrCa patients and 6438 controls. Men had baseline androgen levels drawn and underwent prostate biopsy at 2 and 4 years, or for increases in PSA or abnormal digital rectal exam (DRE). Yet, despite basic science data supporting a role for androgens in PrCa pathogenesis, there are conflicting clinical data on the role of endogenous testosterone in human PrCa pathogenesis de novo. For instance, in the Hypogonadism in Males (HIM) study, 38.7% of men over 45 years met criteria for androgen deficiency, defined as a morning total serum testosterone of Mulligan et al. 2006. Testicular changes with aging include loss of Leydig cells, decreased testosterone production, and decreased responsiveness of the testes to luteinizing hormone (LH) Rubens et al. 1974; Neaves et al. 1984. Accordingly, in the Baltimore Longitudinal Study on Aging (BLSA), roughly 10% of men in their 40s and 25% of men in their 70s were hypogonadal, based on serum testosterone levels Harman et al. 2001. The two principal androgens in men are testosterone, produced by testicular Leydig cells, and dihydrotestosterone (DHT), produced from testosterone in peripheral tissues by 5-α reductase.}
When testosterone levels are very low, cancer cells can adjust by finding new ways to grow and survive. In his clinic, he saw that men with very low testosterone still developed prostate cancer that was often more aggressive, while men receiving testosterone therapy did not show the expected rise in cancer rates. All prostate cells, whether healthy or cancerous, contain androgen receptors. - https://git.huwhy.cn/danutaatkins82/1259git.craigsau.dev/wiki/Testosterone-What-It-Does-And-Doesn%27
